Skip to main content
Erschienen in: Pediatric Cardiology 3/2008

01.05.2008 | Original Article

Postoperative Chylothorax Development Is Associated with Increased Incidence and Risk Profile for Central Venous Thromboses

verfasst von: M. A. McCulloch, M. R. Conaway, J. A. Haizlip, M. L. Buck, V. E. Bovbjerg, T. R. Hoke

Erschienen in: Pediatric Cardiology | Ausgabe 3/2008

Einloggen, um Zugang zu erhalten

Abstract

This study tested the hypothesis that pediatric patients who develop chylothorax (CTX) after surgery for congenital heart disease (CHD) have an elevated incidence and risk profile for central venous thrombosis (CVT). We evaluated 30 patients who developed CTX after surgery for CHD. All but one CTX patient were surgery-, anatomy-, and age-matched with two controls (NON-CTX) to compare their relative risk and incidence of CVT. Using conditional logistic regression analyses, CTX development was associated with significantly longer ventilator dependence (14.8 ± 10.9 vs. 6.1 ± 5.9 days, p = 0.003) and a non-significant trend towards more days of central venous catheters (CVC) (19.1 ± 16.6 vs. 12.2 ± 10.0 days; p = 0.16) when comparing the period prior to CTX development with the entire hospitalization in NON-CTX patients. CTX development was associated with a significantly elevated mortality risk (Odds Ratio 6.2, 95% CI 1.3–30.9). Minimum and mean daily central venous pressures were significantly higher in the CTX group. Post operative need for extracorporeal membrane oxygenation conferred an increased risk of CTX development in this sample of patients (Odds Ratio 9.9, 95% CI 2.2–44.8). Incidence of documented CVT was 26.7% in the CTX group versus 5.1% in the NON-CTX group. Prospective screening for CVT risk and formation, combined with early removal of CVC may help reduce the incidence of CTX.
Literatur
1.
Zurück zum Zitat Al-Zubairy SA, Al-Jazairi AS (2003) Octreotide as a therapeutic option for management of chylothorax. Ann Pharmacother 37:679–682PubMedCrossRef Al-Zubairy SA, Al-Jazairi AS (2003) Octreotide as a therapeutic option for management of chylothorax. Ann Pharmacother 37:679–682PubMedCrossRef
2.
Zurück zum Zitat Anton N, Massicotte MP (2001) Venous thromboembolism in pediatrics. Semin Vasc Med 1:111–122PubMedCrossRef Anton N, Massicotte MP (2001) Venous thromboembolism in pediatrics. Semin Vasc Med 1:111–122PubMedCrossRef
3.
Zurück zum Zitat Berkenbosch JW, Monteleone PM, Tobias JD (2003) Chylothorax following apparently spontaneous central venous thrombosis in a patient with septic shock. Pediatr Pulmonol 35:230–233PubMedCrossRef Berkenbosch JW, Monteleone PM, Tobias JD (2003) Chylothorax following apparently spontaneous central venous thrombosis in a patient with septic shock. Pediatr Pulmonol 35:230–233PubMedCrossRef
4.
Zurück zum Zitat Berkenbosch JW, Withington DE (1999) Management of postoperative chylothorax with nitric oxide: a case report. Crit Care Med 27:1022–1024PubMedCrossRef Berkenbosch JW, Withington DE (1999) Management of postoperative chylothorax with nitric oxide: a case report. Crit Care Med 27:1022–1024PubMedCrossRef
5.
Zurück zum Zitat Bernet-Buettiker V, Waldvogel K, Cannizzaro V, et al. (2006) ntithrombin activity in children with chylothorax. Eur J Cardio-Thor Surg 29:406–409CrossRef Bernet-Buettiker V, Waldvogel K, Cannizzaro V, et al. (2006) ntithrombin activity in children with chylothorax. Eur J Cardio-Thor Surg 29:406–409CrossRef
6.
Zurück zum Zitat Brissaud O, Desfrere L, Mohsen R, et al. (2003) Congenital idiopathic chylothorax in neonates: chemical pleurodesis with povidone-iodine (Betadine). Arch Dis Child Fetal Neonatal Ed 88:F531–F533PubMedCrossRef Brissaud O, Desfrere L, Mohsen R, et al. (2003) Congenital idiopathic chylothorax in neonates: chemical pleurodesis with povidone-iodine (Betadine). Arch Dis Child Fetal Neonatal Ed 88:F531–F533PubMedCrossRef
7.
Zurück zum Zitat Buck ML (2004) Octreotide for the management of chylothorax in infants and children. UVa Pediatr Pharmacother Month Newsletter 10:1–4 Buck ML (2004) Octreotide for the management of chylothorax in infants and children. UVa Pediatr Pharmacother Month Newsletter 10:1–4
8.
Zurück zum Zitat Buttiker V, Fanconi S, Burger R (1999) Chylothorax in children: guidelines for diagnosis and management. Chest 116:682–687PubMedCrossRef Buttiker V, Fanconi S, Burger R (1999) Chylothorax in children: guidelines for diagnosis and management. Chest 116:682–687PubMedCrossRef
9.
Zurück zum Zitat Campbell RM, Benson LN, Williams WW, et al. (2001) Chylopericardium after cardiac operations in children. Ann Thorac Surg 72:193–196PubMedCrossRef Campbell RM, Benson LN, Williams WW, et al. (2001) Chylopericardium after cardiac operations in children. Ann Thorac Surg 72:193–196PubMedCrossRef
10.
Zurück zum Zitat Chan EH, Russell JL, Williams WG, et al. (2005) Postoperative chylothorax after cardiothoracic surgery in children. Ann Thorac Surg 80:1864–1870PubMedCrossRef Chan EH, Russell JL, Williams WG, et al. (2005) Postoperative chylothorax after cardiothoracic surgery in children. Ann Thorac Surg 80:1864–1870PubMedCrossRef
11.
Zurück zum Zitat Cheung Y-f, Leung MP, Yip M-m (2001) Octreotide for treatment of postoperative chylothorax. J Pediatr 139:157–159PubMedCrossRef Cheung Y-f, Leung MP, Yip M-m (2001) Octreotide for treatment of postoperative chylothorax. J Pediatr 139:157–159PubMedCrossRef
12.
Zurück zum Zitat Cormack BE, Wilson NJ, Finucane K, et al. (2004) Use of Monogen for pediatric postoperative chylothorax. Ann Thorac Surg 77:301–305PubMedCrossRef Cormack BE, Wilson NJ, Finucane K, et al. (2004) Use of Monogen for pediatric postoperative chylothorax. Ann Thorac Surg 77:301–305PubMedCrossRef
13.
Zurück zum Zitat Demos NJ, Kozel J, Scerbo JE (2001) Somatostatin in the treatment of chylothorax. Chest 119:964–966PubMedCrossRef Demos NJ, Kozel J, Scerbo JE (2001) Somatostatin in the treatment of chylothorax. Chest 119:964–966PubMedCrossRef
14.
Zurück zum Zitat Dhande V, Kattwinkel J, Alford B (1983) Recurrent bilateral pleural effusions secondary to superior vena cava obstruction as a complication of central venous catheterization. Pediatrics 72:109–113PubMed Dhande V, Kattwinkel J, Alford B (1983) Recurrent bilateral pleural effusions secondary to superior vena cava obstruction as a complication of central venous catheterization. Pediatrics 72:109–113PubMed
15.
Zurück zum Zitat Fernandez Alvarez JR, Kalache KD, Grauel EL (1999) Management of spontaneous congenital chylothorax: oral medium-chain triglycerides versus total parenteral nutrition. Am J Perinatol 16:415–420PubMedCrossRef Fernandez Alvarez JR, Kalache KD, Grauel EL (1999) Management of spontaneous congenital chylothorax: oral medium-chain triglycerides versus total parenteral nutrition. Am J Perinatol 16:415–420PubMedCrossRef
16.
Zurück zum Zitat Hanna J, Truemper E, Burton E (1997) Superior vena cava thrombosis and chylothorax: relationship in pediatric nephrotic syndrome. Pediatr Nephrol 11:20–22PubMedCrossRef Hanna J, Truemper E, Burton E (1997) Superior vena cava thrombosis and chylothorax: relationship in pediatric nephrotic syndrome. Pediatr Nephrol 11:20–22PubMedCrossRef
17.
Zurück zum Zitat Horigome H, Murakami T, Isobe T, et al. (2003) Soluble P-selectin and thrombomodulin-protein C-protein S pathway in cyanotic congenital heart disease with secondary erythrocytosis. Thromb Res 112:223–227PubMedCrossRef Horigome H, Murakami T, Isobe T, et al. (2003) Soluble P-selectin and thrombomodulin-protein C-protein S pathway in cyanotic congenital heart disease with secondary erythrocytosis. Thromb Res 112:223–227PubMedCrossRef
18.
Zurück zum Zitat Krafte-Jacobs B, Sivit CJ, Mejia R, et al. (1995) Catheter-related thrombosis in critically ill children: comparison of catheters with and without heparin bonding. J Pediatr 126:50–54PubMedCrossRef Krafte-Jacobs B, Sivit CJ, Mejia R, et al. (1995) Catheter-related thrombosis in critically ill children: comparison of catheters with and without heparin bonding. J Pediatr 126:50–54PubMedCrossRef
19.
Zurück zum Zitat Kurekci E, Kaye R, Koehler M (1998) Chylothorax and hylopericardium: a complication of a central venous catheter. J Pediatr 132:1064–1066PubMedCrossRef Kurekci E, Kaye R, Koehler M (1998) Chylothorax and hylopericardium: a complication of a central venous catheter. J Pediatr 132:1064–1066PubMedCrossRef
20.
Zurück zum Zitat Landvoigt MT, Mullett CJ (2006) Octreotide efficacy in the treatment of chylothoraces following cardiac surgery in infants and children. Pediatr Crit Care Med 7:245–248PubMedCrossRef Landvoigt MT, Mullett CJ (2006) Octreotide efficacy in the treatment of chylothoraces following cardiac surgery in infants and children. Pediatr Crit Care Med 7:245–248PubMedCrossRef
21.
Zurück zum Zitat Makin A, Silverman SH, Lip GYH (2002) Peripheral vascular disease and Virchow's triad for thrombogenesis. Q J Med 95:199–210 Makin A, Silverman SH, Lip GYH (2002) Peripheral vascular disease and Virchow's triad for thrombogenesis. Q J Med 95:199–210
22.
Zurück zum Zitat Manghat N, Hancock J, Walsh M, et al. (2004) Thrombolysis for central venous occlusion causing bilateral chylothorax in a patient with Down syndrome. J Vasc Interv Radiol 15:511–515PubMed Manghat N, Hancock J, Walsh M, et al. (2004) Thrombolysis for central venous occlusion causing bilateral chylothorax in a patient with Down syndrome. J Vasc Interv Radiol 15:511–515PubMed
23.
Zurück zum Zitat Mohseni-Bod H, Macrae D, Slavik Z (2004) Somatostatin analog (octreotide) in management of neonatal postoperative chylothorax: Is it safe? Pediatr Crit Care Med 5:356–357PubMedCrossRef Mohseni-Bod H, Macrae D, Slavik Z (2004) Somatostatin analog (octreotide) in management of neonatal postoperative chylothorax: Is it safe? Pediatr Crit Care Med 5:356–357PubMedCrossRef
24.
25.
Zurück zum Zitat Monagle P, Chan A, Massicotte P, et al. (2004) Antithrombotic therapy in children: the Seventh ACCP Conference on antithrombotic and thrombolytic therapy. Chest 126(Suppl 3):645S–687SPubMedCrossRef Monagle P, Chan A, Massicotte P, et al. (2004) Antithrombotic therapy in children: the Seventh ACCP Conference on antithrombotic and thrombolytic therapy. Chest 126(Suppl 3):645S–687SPubMedCrossRef
26.
Zurück zum Zitat Moore RA, McNicholas KW, Naidech H, et al. (1985) Clinically silent venous thrombosis following internal and external jugular central venous cannulation in pediatric cardiac patients. Anesthesiology 62:640–643PubMedCrossRef Moore RA, McNicholas KW, Naidech H, et al. (1985) Clinically silent venous thrombosis following internal and external jugular central venous cannulation in pediatric cardiac patients. Anesthesiology 62:640–643PubMedCrossRef
27.
Zurück zum Zitat Nguyen DM, Shum-Tim D, Dobell AR, et al. (1995) The management of chylothorax/chylopericardium following pediatric cardiac surgery: a 10-year experience. J Card Surg 10:302–308PubMedCrossRef Nguyen DM, Shum-Tim D, Dobell AR, et al. (1995) The management of chylothorax/chylopericardium following pediatric cardiac surgery: a 10-year experience. J Card Surg 10:302–308PubMedCrossRef
28.
Zurück zum Zitat Petaja J, Lundstrom U, Sairenen H, et al. (1996) Central venous thrombosis after cardiac operations in children. J Thorac Cardiovasc Surg 112:883–889PubMedCrossRef Petaja J, Lundstrom U, Sairenen H, et al. (1996) Central venous thrombosis after cardiac operations in children. J Thorac Cardiovasc Surg 112:883–889PubMedCrossRef
29.
Zurück zum Zitat Petaja J, Peltola K, Sairenen H, et al. (1996) Fibrinolysis, antithrombin III, and protein C in neonates during cardiac operations. J Thorac Cardiovasc Surg 112:665–671PubMedCrossRef Petaja J, Peltola K, Sairenen H, et al. (1996) Fibrinolysis, antithrombin III, and protein C in neonates during cardiac operations. J Thorac Cardiovasc Surg 112:665–671PubMedCrossRef
30.
Zurück zum Zitat Pratap U, Slavik Z, Ofoe VD, et al. (2001) Octreotide to treat postoperative chylothorax after cardiac operations in children. Ann Thorac Surg 72:1740–1742PubMedCrossRef Pratap U, Slavik Z, Ofoe VD, et al. (2001) Octreotide to treat postoperative chylothorax after cardiac operations in children. Ann Thorac Surg 72:1740–1742PubMedCrossRef
31.
Zurück zum Zitat Rimensberger PC, Muller-Schenker B, Kalangos A, et al. (1998) Treatment of a persistent postoperative chylothorax with somatostatin. Ann Thorac Surg 66:253–254PubMedCrossRef Rimensberger PC, Muller-Schenker B, Kalangos A, et al. (1998) Treatment of a persistent postoperative chylothorax with somatostatin. Ann Thorac Surg 66:253–254PubMedCrossRef
32.
Zurück zum Zitat Rosti L, Bini R, Chessa M, et al. (2002) The effectiveness of octreotide in the treatment of post-operative chylothorax. Eur J Pediatr 161:149–150PubMedCrossRef Rosti L, Bini R, Chessa M, et al. (2002) The effectiveness of octreotide in the treatment of post-operative chylothorax. Eur J Pediatr 161:149–150PubMedCrossRef
33.
Zurück zum Zitat Rosti L, De Battisti F, Butera G, et al. (2005) Octreotide in the management of postoperative chylothorax. Pediatr Cardiol 26:440–443PubMedCrossRef Rosti L, De Battisti F, Butera G, et al. (2005) Octreotide in the management of postoperative chylothorax. Pediatr Cardiol 26:440–443PubMedCrossRef
34.
Zurück zum Zitat Wolff AB, Silen ML, Kokoska ER, et al. (1999) Treatment of refractory chylothorax with externalized pleuroperitoneal shunts in children. Ann Thorac Surg 68:1053–1057PubMedCrossRef Wolff AB, Silen ML, Kokoska ER, et al. (1999) Treatment of refractory chylothorax with externalized pleuroperitoneal shunts in children. Ann Thorac Surg 68:1053–1057PubMedCrossRef
Metadaten
Titel
Postoperative Chylothorax Development Is Associated with Increased Incidence and Risk Profile for Central Venous Thromboses
verfasst von
M. A. McCulloch
M. R. Conaway
J. A. Haizlip
M. L. Buck
V. E. Bovbjerg
T. R. Hoke
Publikationsdatum
01.05.2008
Verlag
Springer-Verlag
Erschienen in
Pediatric Cardiology / Ausgabe 3/2008
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-007-9140-9

Weitere Artikel der Ausgabe 3/2008

Pediatric Cardiology 3/2008 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.